תרים 25
unipharm ltd, israel - sildenafil as citrate - טבליות מצופות פילם - sildenafil as citrate 25 mg - sildenafil
סילדזן
taro international ltd, israel - sildenafil as citrate - תרחיף - sildenafil as citrate 25 mg / 1 ml - sildenafil
סילדנאפיל טבע ® 25 מ"ג
salomon,levin & elstein ltd - sildenafil as citrate 25 mg - film coated tablets - sildenafil - sildenafil teva ® 25 mg fc tablets is indicated for the treatment of erectile dysfunction.
סילדנאפיל טבע ® 50 מ"ג
salomon,levin & elstein ltd - sildenafil as citrate 50 mg - film coated tablets - sildenafil - sildenafil teva® 50 mg fc tablets is indicated for the treatment of erectile dysfunction.
סיל - און 25
rafa laboratories ltd - sildenafil 25 mg - film coated tablets - sildenafil - treatment of erectile dysfunction.
סיל - און 50
rafa laboratories ltd - sildenafil 50 mg - film coated tablets - sildenafil - treatment of erectile dysfunction.
סיל - און 100
rafa laboratories ltd - sildenafil 100 mg - film coated tablets - sildenafil - treatment of erectile dysfunction.
טרקליר 62.5 מג
j-c health care ltd - bosentan - טבליות מצופות פילם - bosentan 62.5 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease
טרקליר 125 מג
j-c health care ltd - bosentan - טבליות מצופות פילם - bosentan 125 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease
פלולן אפופרוסטנול 1500 מקג לעירוי
glaxo smith kline (israel) ltd - epoprostenol as sodium - אבקה להכנת תמיסה לאינפוזיה - epoprostenol as sodium 1.5 mg/vial - epoprostenol - epoprostenol - flolan is indicated for the long-term intravenous treatment of primary arterial pulmonary hypertension and arterial pulmonary hypertension associated with the scleroderma spectrum of disease in nyha class iii and class iv patients who do not respond to conventional therapy.